ROR gamma (RORγ) modulators
Abstract:
The present application relates to compounds according to (Formula IA) or (Formula IB): or a pharmaceutically acceptable salt thereof. The compounds can be used as inhibitors of RORγ and are useful for the treatment of RORγ mediated diseases.
Information query
Patent Agency Ranking
0/0